Last10K.com

Cactus Ventures, Inc. (ATNM) SEC Filing 10-K Annual report for the fiscal year ending Saturday, December 31, 2011

Actinium Pharmaceuticals, Inc.

HISTORY TOOLS
CIK: 1892322 Ticker: ATNM
Document and Entity Information (USD $)
 12 Months Ended
Dec. 31, 2011
Mar. 07, 2012
Document and Entity Information    
Entity Registrant Name Cactus Ventures, Inc.  
Document Type 10-K  
Document Period End Date Dec. 31, 2011  
Amendment Flag false  
Entity Central Index Key 0001388320  
Current Fiscal Year End Date --12-31  
Entity Common Stock, Shares Outstanding   11,155,008
Entity Public Float   $ 0
Entity Filer Category Smaller Reporting Company  
Entity Current Reporting Status Yes  
Entity Voluntary Filers No  
Entity Well-known Seasoned Issuer No  
Document Fiscal Year Focus 2011  
Document Fiscal Period Focus FY  

View differences made from one year to another to evaluate Actinium Pharmaceuticals, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Actinium Pharmaceuticals, Inc..

Continue

Assess how Actinium Pharmaceuticals, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Actinium Pharmaceuticals, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2012 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Actinium Pharmaceuticals, Inc. provided additional information to their SEC Filing as exhibits

Exhibit 31.1: Rule 13A-14(A)/15D-14(A) Certification
Exhibit 32.1: Section 1350 Certification
Ticker: ATNM
CIK: 1388320
Form Type: 10-K Annual Report
Accession Number: 0001078782-12-001008
Submitted to the SEC: Thu Apr 12 2012 2:45:29 PM EST
Accepted by the SEC: Thu Apr 12 2012
Period: Saturday, December 31, 2011
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/atnm/0001078782-12-001008.htm